in Newswire Published on September 18, 2023

Class Action Alleges CVS Pink Eye Drops Are Misbranded, Require FDA Approval

Jordan v. CVS Pharmacy, Inc.

Filed: September 17, 2023 § 1:23-cv-00979

CVS Pharmacy has been hit with a class action after it received an FDA warning letter about its over-the-counter CVS Health Pink Eye Relief Drops.

Case Spotlight

Hair Relaxer Lawsuits Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on September 18, 2023 — 4:19 PM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.